InstaMed, a J.P. Morgan company
InstaMed, a J.P. Morgan company, provides a healthcare payments network and platform that connects providers, payers, and consumers to streamline the collection, processing, and reconciliation of medical payments. The company offers cloud-based tools for patient billing, payment processing, and revenue cycle workflows, generating revenue through transaction fees and related payment and software services. Its solutions are used by hospitals, health systems, physician practices, and health plans across the United States.
- Payment Processing
- Revenue Cycle Management
- Electronic Health Records
- Revenue
- $90.0M
- Employees
- 350
- Founded
- 2004
- Headquarters
- Philadelphia, United States of America
What 9 Arbolus experts think of InstaMed, a J.P. Morgan company
NPS scores range from 4 to 10, with the majority above 7. 67% of responses are Promoters (NPS 9-10), 22% are Passives (NPS 7-8), and 11% are Detractors (NPS ≤6). 80% with disclosed renewal intent intend to renew, reflecting strong stickiness. Most customers are in the MoreThan1Year implementation stage, indicating mature product adoption. The strongest positive sentiment aligns with high spend and influencer roles, while lower spend and 'Not Sure' renewal is limited to a minority.Overall Customer Sentiment: Positive
Who reviewed InstaMed, a J.P. Morgan company
- C-Suite 67% (6)
- Director 22% (2)
- Manager 11% (1)
Employer names and spend open once the report publishes.
Tell us when the InstaMed, a J.P. Morgan company report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
22 Net Promoter Score, from 9 scored reviews- Promoters 4
- Passives 3
- Detractors 2
Cumulative NPS by month
-1 over 6 months- Dec 9
- Jan 9
- Apr 8
- May 8
- Jul 8
- Aug 8
Net Promoter Score across 2 reviews, accumulated up to each month. Category median 24 across 2 companies.
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 83%Plan to renew, by seniority
- 80% 5 answers
- 100% 1 answer
- 9.2/10 Average score from customers who will renew
- 4/10 Average score from undecided customers
Top alternatives
Most weighed by InstaMed, a J.P. Morgan company customers
More in Commerce & Marketplaces
Other companies in Commerce & Marketplaces with a customer report.
For people who use InstaMed, a J.P. Morgan company
Do you use InstaMed, a J.P. Morgan company at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 9 customers of InstaMed, a J.P. Morgan company have already contributed
Takes a few minutes. Your identity stays anonymous.